Tokyo Tape
Sign in
← Prism BioLab

Annual report

206A.TEDINET S100V11F
Period2023-10-01 → 2024-09-30
Filed2024-12-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 69
MetricValuePeriodScopeSource row
Revenue¥306m2023-10-01 → 2024-09-30StandaloneNet sales
Revenue¥113m2022-10-01 → 2023-09-30StandaloneNet sales
Revenue¥554m2021-10-01 → 2022-09-30dStandaloneNet sales (5-year summary)
Revenue¥59m2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Revenue¥206m2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Operating income−¥782m2023-10-01 → 2024-09-30StandaloneOperating income
Operating income−¥497m2022-10-01 → 2023-09-30StandaloneOperating income
Ordinary income−¥832m2023-10-01 → 2024-09-30StandaloneOrdinary income
Ordinary income−¥498m2022-10-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥79m2021-10-01 → 2022-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥154m2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥140m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.0bn2023-10-01 → 2024-09-30StandaloneIncome before income taxes
Profit before tax−¥526m2022-10-01 → 2023-09-30StandaloneIncome before income taxes
Net income−¥1.0bn2023-10-01 → 2024-09-30StandaloneProfit loss
Net income−¥527m2022-10-01 → 2023-09-30StandaloneProfit loss
Net income¥73m2021-10-01 → 2022-09-30dStandaloneNet income loss (5-year summary)
Net income−¥156m2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Net income−¥143m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Total assets¥4.5bnat 2024-09-30StandaloneAssets
Total assets¥1.2bnat 2023-09-30StandaloneAssets
Total assets¥1.7bnat 2022-09-30dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total assets¥401mat 2020-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥1.0bnat 2024-09-30StandaloneLiabilities
Total liabilities¥63mat 2023-09-30StandaloneLiabilities
Net assets / equity¥3.5bnat 2024-09-30StandaloneNet assets
Net assets / equity¥1.1bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.7bnat 2022-09-30dStandaloneNet assets
Net assets / equity¥1.1bnat 2021-09-30dStandaloneNet assets (5-year summary)
Net assets / equity−¥51mat 2020-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥4.4bnat 2024-09-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2023-09-30StandaloneCash and deposits
Cash & equivalents¥4.4bnat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2022-09-30dStandaloneCash and cash equivalents
Operating cash flow¥150m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥514m2022-10-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥103m2021-10-01 → 2022-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥244m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥40m2022-10-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥8m2021-10-01 → 2022-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.4bn2023-10-01 → 2024-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥111m2021-10-01 → 2022-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-33.532023-10-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-19.092022-10-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥2.672021-10-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1,556.872020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1,469.952019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥97.41at 2024-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥-34.5at 2023-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥-15.41at 2022-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥-6,231.85at 2021-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥-6,711.33at 2020-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio77.3%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio94.7%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio96.2%at 2022-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio72.4%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE5.3%2021-10-01 → 2022-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued35,954,800at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued80,524at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued80,524at 2022-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued77,078at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued77,078at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees27at 2024-09-30StandaloneNumber of employees
Employees17at 2023-09-30StandaloneNumber of employees
Employees12at 2022-09-30dStandaloneNumber of employees
Employees7at 2021-09-30dStandaloneNumber of employees
Employees6at 2020-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 738
ItemContextValueUnit
Proceeds from collection of lease and guarantee deposits inv cfCurrentYearDuration_NonConsolidatedMember17376000JPY
Payments for lease and guarantee deposits inv cfPrior1YearDuration_NonConsolidatedMember-5784000JPY
Payments for lease and guarantee deposits inv cfCurrentYearDuration_NonConsolidatedMember-49936000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-40377000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-244187000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration_NonConsolidatedMember3390902000JPY
Payments of listing expenses fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Payments of listing expenses fin cfCurrentYearDuration_NonConsolidatedMember-20846000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember－JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember3370055000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember138000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember-17934000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember-554050000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember3258079000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1687993000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1133943000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1133943000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember4392022000JPY
Compensations sgaPrior1YearDuration_NonConsolidatedMember68261000JPY
Compensations sgaCurrentYearDuration_NonConsolidatedMember94734000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember359000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember－JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember338734000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember571628000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember338734000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember571628000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-12-27
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第13期(自　2023年10月１日　至　2024年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社PRISM BioLab
Company name in english cover pageFilingDateInstantPRISM BioLab Co.,LTD
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役　竹原　大
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)神奈川県藤沢市村岡東二丁目26番１号
Telephone number address of registered headquarter cover pageFilingDateInstant0466-53-8383
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　管理部長　武内　伸治
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)神奈川県藤沢市村岡東二丁目26番１号
Telephone number nearest place of contact cover pageFilingDateInstant0466-53-8383
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　管理部長　武内　伸治
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE39751
Fund codeFilingDateInstant－
Security codeFilingDateInstant206A0
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社ＰＲＩＳＭ　ＢｉｏＬａｂ
Filer name in englishFilingDateInstantPRISM BioLab Co.,LTD
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-09-30pass rounding
balance sheet identitynon_consolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-10-01/2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2022-10-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass